Welcome
|
The use of biomarkers is playing an ever-increasing role in both the pre-clinical and clinical phases of drug discovery, as well as its more traditional role as a core activity for many diagnostic companies. From target identification and validation, through pre-clinical and early clinical phases, the ability to predict or follow drug effects in vivo can significantly reduce the cost and time taken to develop new drugs. |
Understanding and harnessing the power of biomarkers is, however, a considerable challenge, not least because of the wide range of specialist skill sets that are required. Getting it right offers the prospect of a concrete commercial advantage over your competitors, but pitfalls abound and reliance on a poorly validated surrogate biomarker could spell disaster. Partnership with a contract research company, like Total Scientific, whose expertise is focussed entirely on the identification, measurement and analysis of biomarkers, is the best way to navigate this minefield with confidence, and leverage our skills to your commercial advantage.
Together with the scientific capability to ensure that your project delivers its objectives, we offer a first-class service to our clients. Each project has a dedicated project manager, a scientist who is in charge of delivering the project to you, who gives you regular project updates and provides you with easy access to someone who can help you with any queries.
For more information about the biomarker services we offer, or Total Scientific Ltd and its staff please explore our website further.
|
